AF
LLY icon

Alerus Financial’s Eli Lilly LLY Stock Holding History

Alerus Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7M Sell
18,122
-1,582
-8% -$1.6M 0.83% 18
2025
Q4 		$21.2M Sell
19,704
-343
-2% -$328K 1.04% 15
2025
Q3 		$15.3M Buy
20,047
+816
+4% +$607K 0.78% 19
2025
Q2 		$15M Sell
19,231
-114
-0.6% -$88.6K 1.08% 19
2025
Q1 		$16M Sell
19,345
-55
-0.3% -$45.8K 1.28% 15
2024
Q4 		$15M Sell
19,400
-1,107
-5% -$917K 1.15% 18
2024
Q3 		$18.2M Sell
20,507
-1,281
-6% -$1.15M 1.33% 15
2024
Q2 		$19.7M Sell
21,788
-1,128
-5% -$902K 1.47% 15
2024
Q1 		$17.8M Sell
22,916
-920
-4% -$655K 1.35% 16
2023
Q4 		$13.9M Buy
23,836
+6,246
+36% +$3.65M 1.13% 16
2023
Q3 		$9.45M Sell
17,590
-4,862
-22% -$2.51M 0.84% 27
2023
Q2 		$10.5M Sell
22,452
-691
-3% -$290K 0.89% 26
2023
Q1 		$7.95M Buy
23,143
+854
+4% +$288K 0.71% 33
2022
Q4 		$8.15M Buy
22,289
+2,145
+11% +$761K 0.75% 31
2022
Q3 		$6.51M Buy
20,144
+9,538
+90% +$3.02M 0.65% 36
2022
Q2 		$3.44M Sell
10,606
-2,205
-17% -$662K 0.32% 74
2022
Q1 		$3.67M Buy
12,811
+261
+2% +$67.2K 0.31% 85
2021
Q4 		$3.47M Sell
12,550
-3,738
-23% -$948K 0.28% 94
2021
Q3 		$3.76M Sell
16,288
-1,750
-10% -$432K 0.34% 73
2021
Q2 		$4.14M Buy
18,038
+3,865
+27% +$776K 0.42% 63
2021
Q1 		$2.65M Sell
14,173
-9,902
-41% -$1.94M 0.28% 87
2020
Q4 		$4.07M Sell
24,075
-1,096
-4% -$164K 0.41% 61
2020
Q3 		$3.73M Buy
25,171
+17,153
+214% +$2.65M 0.42% 64
2020
Q2 		$1.32M Buy
+8,018
New +$1.23M 0.15% 106

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alerus Financial's LLY Position: Q1 2026 in Review

Alerus Financial reduced its Eli Lilly (LLY) stake by 8% in Q1 2026, selling an estimated $1.6M and leaving 18,122 shares worth $16.7M. The position accounts for 0.83% of the portfolio, ranked #18.

Alerus Financial first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $21.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Alerus Financial held 18,122 shares of Eli Lilly worth $16.7M as of Q1 2026.
  • Alerus Financial sold 1,582 Eli Lilly shares in Q1 2026, an estimated $1.6M.
  • Eli Lilly made up 0.83% of Alerus Financial's portfolio in Q1 2026, its #18 holding.
  • Alerus Financial first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Alerus Financial's Eli Lilly position peaked at $21.2M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.